Published on
October 1, 2024
- 14:00 GMT
BioSymetrics and Moleculera Partner to Advance Personalized Treatment for Immune-mediated Neuropsychiatric Disorders
Alliance will leverage BioSymetrics' Elion Platform and Moleculera’s expansive biorepository and database to develop advanced predictive treatment algorithms NEW YORK, NY, UNITED STATES, October 1, 2024 /EINPresswire.com/ -- BioSymetrics, a leader …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
